Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genelux (GNLX) Shares Outstanding (Diluted Average) (2022 - 2025)

Genelux has reported Shares Outstanding (Diluted Average) over the past 4 years, most recently at $37.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $37.2 million for Q4 2025, up 18.21% from a year ago — trailing twelve months through Dec 2025 was $37.2 million (up 18.21% YoY), and the annual figure for FY2025 was $37.2 million, up 18.21%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $37.2 million at Genelux, down from $37.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for GNLX hit a ceiling of $37.9 million in Q3 2025 and a floor of $9.1 million in Q3 2022.
  • Median Shares Outstanding (Diluted Average) over the past 4 years was $28.3 million (2024), compared with a mean of $26.6 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 167.97% in 2023 and later increased 18.21% in 2025.
  • Genelux's Shares Outstanding (Diluted Average) stood at $9.1 million in 2022, then skyrocketed by 167.97% to $24.4 million in 2023, then rose by 28.74% to $31.5 million in 2024, then grew by 18.21% to $37.2 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $37.2 million (Q4 2025), $37.9 million (Q3 2025), and $36.3 million (Q2 2025) per Business Quant data.